Christopher DeCotiis, MD, is a pulmonologist specializing in critical care medicine, pulmonary disease, and pulmonology with Atlantic Health. Board-certified in internal medicine, pulmonary disease, and critical care medicine by the American Board of Internal Medicine, he has more than 10 years of experience treating disorders of the lungs and respiratory system, including pneumonia, asthma, chronic obstructive pulmonary disease, interstitial lung disease, and lung cancer. He is dedicated to providing compassionate, personalized care to all patients and ensuring they are educated about their condition and treatment.After earning his medical degree from Rutgers-New Jersey Medical School, Newark, NJ, Dr. DeCotiis performed a residency in internal medicine at Georgetown University Hospital, Washington, DC. He then completed a fellowship in pulmonary and critical care at New York University, New York, NY. He serves outpatients in multiple offices in the area and treats hospitalized patients at Overlook Medical Center and Morristown Memorial Medical Center. In addition to general pulmonary and critical care diseases, Dr. DeCotiis has a special interest in lung nodules, lung cancer, and advanced bronchoscopy procedures. He serves in several administrative roles including co-director for the Atlantic Health System Lung Nodule program as well as the Atlantic Health System Interventional Pulmonary program.Dr. DeCotiis is engaged in physician trainee instruction and in community engagement activities for pulmonary disease awareness. He has authored numerous peer-reviewed publications, is a member of the professional organizations American College of Chest Physicians and American Thoracic Society, and is a participating provider of the Atlantic Accountable Care Organization. He was born and raised in New Jersey and is excited to provide care to his community. Dr. Decotiis is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleurisy, Pleural Effusion, Pneumonia, Lung Nodules, and Gastrostomy.

Heather Katz, DO, FACOI, FACP, is a board-certified hematologist and medical oncologist specializing in the diagnosis and treatment of solid tumors and hematologic malignancies. Her clinical expertise includes cancers of the breast, gastrointestinal tract, head and neck, genitourinary system, lung, and gynecologic organs, as well as hematologic conditions such as leukemia, lymphoma, and multiple myeloma. Dr. Katz is committed to delivering comprehensive, evidence-based care grounded in compassion and respect for each patient’s individual journey. She emphasizes shared decision-making, continuity of care, and clear communication to empower patients and their families throughout treatment and survivorship. Dr. Katz earned her Bachelor of Science in Biology, with a minor in Human Development, from the State University of New York at Geneseo. She received her medical degree from Rocky Vista University College of Osteopathic Medicine in Parker, Colorado, and completed her internal medicine residency at Broward Health Medical Center in Fort Lauderdale, Florida, where she served as Chief Resident and was named Resident of the Year. She went on to complete her fellowship in Hematology and Medical Oncology at Marshall University’s Joan C. Edwards School of Medicine in Huntington, West Virginia, serving as Chief Fellow in her final year. Board certified in Internal Medicine, Medical Oncology, and Hematology by the American Osteopathic Board of Internal Medicine, Dr. Katz is a Fellow of both the American College of Osteopathic Internists and the American College of Physicians. She has presented at numerousnational oncology conferences and is the author of over 15 peer-reviewed publications in the medical literature. Dr. Katz is dedicated not only to clinical excellence but also to advancing the field of oncology through research, education, and mentorship. Her patients recognize her for her thoughtful bedside manner, personalized treatment planning, and unwavering commitment to high-quality care. . Dr. Katz is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Salpingo-Oophorectomy.

Keren Bakal is a Pulmonary Medicine provider in Livingston, New Jersey. Dr. Bakal is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Asthma, Lung Metastases, Asthma in Children, and Sarcoidosis. Dr. Bakal is currently accepting new patients.

Gitendra Rajiyah is a Cardiologist in West Orange, New Jersey. Dr. Rajiyah is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Necrosis, Gastrostomy, and Endoscopy. Dr. Rajiyah is currently accepting new patients.

Said Saleh is a Hematologist in West Orange, New Jersey. Dr. Saleh is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy.

James Orsini is a Hematologist in West Orange, New Jersey. Dr. Orsini is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Colorectal Cancer, Iron Deficiency Anemia, Familial Prostate Cancer, and Bone Marrow Aspiration.

Kenneth Blatt is a Radiologist in Maplewood, New Jersey. Dr. Blatt is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleurisy, Pleural Effusion, Nasal Flaring, and Caffey Disease.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Sophie Morse is a Hematologist Oncology specialist and a Hematologist in Summit, New Jersey. Dr. Morse is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

Sarada Gurubhagavatula is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gurubhagavatula is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Gurubhagavatula is currently accepting new patients.

Frederic J. Scoopo, MD, is a pulmonologist specializing in pulmonary disease and critical care medicine with Atlantic Medical Group (AMG). Board-certified in internal medicine with subspecialties in pulmonary disease and critical care medicine by the American Board of Internal Medicine, he has over 25 years of experience treating disorders of the lungs and respiratory system, including interstitial lung disease, chronic obstructive pulmonary disease, asthma, and bronchiectasis. He is dedicated to providing compassionate, personalized care to all patients, and making sure they are educated about their condition and treatment.After earning his medical degree from the University of Connecticut School of Medicine, Farmington, CT, Dr. Scoopo performed a residency in internal medicine and pediatrics at Morristown Memorial Hospital, Morristown, NJ, where he also served as chief resident. He then completed a fellowship in pulmonary and critical care medicine at Hahnemann University School of Medicine, Philadelphia, PA. He has served as medical intensive care unit director at Morristown Medical Center, chair of the Pharmacy and Therapeutics Committee at Morristown Medical Center, and currently serves as a clinical assistant professor at Rutgers New Jersey Medical School. He also holds a BS in chemistry, magna cum laude, from Villanova University, Villanova, PA. He has authored peer-reviewed publications, is a member of the professional organizations the American Thoracic Society and the American College Chest Physicians, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Scoopo is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Nodules, Lung Metastases, Pulmonary Fibrosis, and Chronic Obstructive Pulmonary Disease (COPD).

Shalini Chhabra is a Radiologist in Livingston, New Jersey. Dr. Chhabra is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Gastric Lymphoma, Lymphoid Hyperplasia, Lymphofollicular Hyperplasia, and Metastatic Pleural Tumor.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Marlene is an Advanced Nurse Practitioner at Advanced Care Oncology & Hematology Associates (ACOHA). With several years of adult internal medicine practice experience, Marlene joined ACOHA in 2013 and specializes in managing patients on treatment for anemia, blood clots, and symptoms during chemotherapy treatments.She graduated from the College of New Jersey with a BSN and later graduated with an MSN from UMDNJ with a specialty in adult health.Marlene is an active member of sigma theta tau nursing honor Society-Omicron Pi Chapter. She achieved her Advanced Cardiac Life Support (ACLS) and Basic Life Support (BLS) certifications. Ms. Schmitz is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Ampullary Cancer, Small Lymphocytic Lymphoma (SLL), ALK-Positive Non-Small Cell Lung Cancer, and Smoldering Multiple Myeloma.

Dr. Robert Restifo is a pulmonologist with Atlantic Medical Group Pulmonology. Board-certified in internal medicine and pulmonary disease by the American Board of Internal Medicine, he utilizes state-of-the-art diagnostic tools and treatment options to address both chronic and acute pulmonary disorders that can significantly impact daily life.In practice for more than 34 years, Dr. Restifo finds person-to-person interaction with patients most rewarding. He strives to develop relationships built on trust and confidence with the goal of helping to improve the lives of those coping with respiratory issues. With a calm and caring approach, he takes the time to explain medical findings in a way that is understandable to patients. In addition to his clinical experience, he has participated in numerous clinical investigations throughout his career designed to advance the understanding and treatment of pulmonary disease. He is a fellow of the American College of Chest Physicians (ACCP) and a member of the American Thoracic Society.Dr. Restifo earned his medical degree from UMDNJ School of Osteopathic Medicine. He performed his residency training followed by a fellowship in pulmonary disease at University Hospital of the University of Medicine and Dentistry of NJ (UMDNJ). He is a participating provider of the Atlantic Accountable Care Organization. Dr. Restifo is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Nodules, Lung Metastases, Emphysema, and Bullae.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Primitive Neuroectodermal Tumor (PNET).

Eric Freeman is a Physiatrist and a Pain Medicine provider in Union, New Jersey. Dr. Freeman is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Herniated Disk, Cervical Spondylosis, Spinal Stenosis, and Sacroiliac Joint Disease. Dr. Freeman is currently accepting new patients.

Pratik Patel is an Intensive Care Medicine provider in Newark, New Jersey. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Gastrostomy, and Advanced Bronchoscopy.